Enterotoxigenic Escherichia coli: intestinal pathogenesis mechanisms and colonization resistance by gut microbiota

References

• Anderson JD, Bagamian KH, Muhib F, Amaya MP, Laytner LA, Wierzba T, Rheingans R. Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis. Lancet Glob Health. 2019;7(3):e321–22. doi:10.1016/s2214-109x(18)30483-2.
   PubMed Web of Science ®Google Scholar
• Bagamian KH, Anderson JD, Muhib F, Cumming O, Laytner LA, Wierzba TF, Rheingans R. Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting. Lancet Glob Health. 2020;8(1):e101–e12. doi:10.1016/s2214-109x(19)30456-5.
   PubMed Web of Science ®Google Scholar
• Steffen R, Hill DR, DuPont HL. Traveler’s diarrhea: a clinical review. JAMA. 2015;313(1):71–80. doi:10.1001/jama.2014.17006.
   PubMed Web of Science ®Google Scholar
• Ahmed D, Islam MS, Begum YA, Janzon A, Qadri F, Sjoling A. Presence of enterotoxigenic Escherichia coli in biofilms formed in water containers in poor households coincides with epidemic seasons in Dhaka. J Appl Microbiol. 2013;114(4):1223–1229. doi:10.1111/jam.12109.
   PubMed Web of Science ®Google Scholar
• Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in bangladesh. Infect Immun. 2007;75(8):3961–3968. doi:10.1128/IAI.00459-07.
   PubMed Web of Science ®Google Scholar
• Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia col in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev. 2005;18(3):465–483. doi:10.1128/CMR.18.3.465-483.2005.
   PubMed Web of Science ®Google Scholar
• Fleckenstein JM, Hardwidge PR, Munson GP, Rasko DA, Sommerfelt H, Steinsland H. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect. 2010;12(2):89–98. doi:10.1016/j.micinf.2009.10.002.
   PubMed Web of Science ®Google Scholar
• Finkelstein RA, Vasil ML, Jones JR, Anderson RA, Barnard Tjjo CM. Clinical cholera caused by enterotoxigenic Escherichia coli. J Clin Microbiol. 1976;3(3):382–384. doi:10.1128/jcm.3.3.382-384.1976.
   PubMed Web of Science ®Google Scholar
• Youmans BP, Ajami NJ, Jiang Z-D, Campbell F, Wadsworth WD, Petrosino JF, DuPont HL, Highlander SK. Characterization of the human gut microbiome during travelers’ diarrhea. Gut Microbes. 2015;6(2):110–119. doi:10.1080/19490976.2015.1019693.
   PubMed Web of Science ®Google Scholar
• Troeger C, Colombara DV, Rao PC, Khalil IA, Brown A, Brewer TG, Guerrant RL, Houpt ER, Kotloff KL, Misra K, et al. Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years. Lancet Glob Health. 2018;6:e255–e69. doi:10.1016/s2214-109x(18)30045-7.
   PubMed Web of Science ®Google Scholar
• Platts-Mills JA, Taniuchi M, Uddin MJ, Sobuz SU, Mahfuz M, Gaffar SA, Mondal D, Hossain MI, Islam MM, Ahmed AS; JTAjocn. Association between enteropathogens and malnutrition in children aged 6–23 mo in Bangladesh: a case-control study. Am J Clin Nutr. 2017;105(5):1132–1138. doi:10.3945/ajcn.116.138800.
   PubMed Web of Science ®Google Scholar
• Madhavan TP, Sakellaris H. Colonization factors of enterotoxigenic Escherichia coli. Adv Appl Microbiol. 2015;90:155–197. doi:10.1016/bs.aambs.2014.09.003.
   PubMed Web of Science ®Google Scholar
• Karjalainen TK, Evans D, So M, Lee C-H. Molecular cloning and nucleotide sequence of the colonization factor antigen I gene of Escherichia coli. Infect Immun. 1989;57(4):1126–1130. doi:10.1128/iai.57.4.1126-1130.1989.
   PubMed Web of Science ®Google Scholar
• Evans DG, Evans JDJ, Clegg S, Pauley JA. Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli. Infect Immun. 1979;25(2):738–748. doi:10.1128/iai.25.2.738-748.1979.
   PubMed Web of Science ®Google Scholar
• Froehlich BJ, Karakashian A, Meisen LR, Wakefield JC, Scott JR. CooC and CooD are required for assembly of CS1 pili. Mol Microbiol. 1994;12(3):387–401. doi:10.1111/j.1365-2958.1994.tb01028.x.
   PubMed Web of Science ®Google Scholar
• Perez-Casal J, Swartley JS, Scott JR. Gene encoding the major subunit of CS1 pili of human enterotoxigenic Escherichia coli. Infect Immun. 1990;58(11):3594–3600. doi:10.1128/iai.58.11.3594-3600.1990.
   PubMed Web of Science ®Google Scholar
• Froehlich BJ, Karakashian A, Sakellaris H, Scott JR. Genes for CS2 pili of enterotoxigenic Escherichia coli and their interchangeability with those for CS1 pili. Infect Immun. 1995;63(12):4849–4856. doi:10.1128/iai.63.12.4849-4856.1995.
   PubMed Web of Science ®Google Scholar
• Jalajakumari M, Thomas C, Halter R, Manning P. Genes for biosynthesis and assembly of CS3 pili of CFA/II enterotoxigenic Escherichia coli: novel regulation of pilus production by bypassing an amber codon. Mol Microbiol. 1989;3(12):1685–1695. doi:10.1111/j.1365-2958.1989.tb00154.x.
   PubMed Web of Science ®Google Scholar
• Levine MM, Ristaino P, Marley G, Smyth C, Knutton S, Boedeker E, Black R, Young C, Clements ML, Cheney C. Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans. Infect Immun. 1984;44(2):409–420. doi:10.1128/iai.44.2.409-420.1984.
   PubMed Web of Science ®Google Scholar
• Wolf MK, Andrews G, Tall B, McConnell M, Levine M, Boedeker E. Characterization of CS4 and CS6 antigenic components of PCF8775, a putative colonization factor complex from enterotoxigenic Escherichia coli E8775. Infect Immun. 1989;57(1):164–173. doi:10.1128/iai.57.1.164-173.1989.
   PubMed Web of Science ®Google Scholar
• Anantha RP, McVeigh AL, Lee LH, Agnew MK, Cassels FJ, Scott DA, Whittam TS, Savarino SJ. Evolutionary and functional relationships of colonization factor antigen I and other class 5 adhesive fimbriae of enterotoxigenic Escherichia coli. Infect Immun. 2004;72(12):7190–7201. doi:10.1128/IAI.72.12.7190-7201.2004.
   PubMed Web of Science ®Google Scholar
• Manning PA, Higgins GD, Lumb R, Lanser JA. Colonization factor antigens and a new fimbrial type, CFA/V, on O115: H40 and H⁻ strains of enterotoxigenic Escherichia coli in Central Australia. J Infect Dis. 1987;156(5):841–844. doi:10.1093/infdis/156.5.841.
   PubMed Web of Science ®Google Scholar
• Clark CA, Heuzenroeder MW, Manning PA. Colonization factor antigen CFA/IV (PCF8775) of human enterotoxigenic Escherichia coli: nucleotide sequence of the CS5 determinant. Infect Immun. 1992;60(3):1254–1257. doi:10.1128/iai.60.3.1254-1257.1992.
   PubMed Web of Science ®Google Scholar
• Duthy TG, Staendner LH, Manning PA, Heuzenroeder MW. CS5 pilus biosynthesis genes from enterotoxigenic Escherichia coli O115:H40. J Bacteriol. 1999;181(18):5847–5851. doi:10.1128/JB.181.18.5847-5851.1999.
   PubMed Web of Science ®Google Scholar
• Wolf MK, De Haan LA, Cassels FJ, Willshaw GA, Warren R, Boedeker EC, Gaastra W. The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunits. FEMS Microbiol Lett. 1997;148(1):35–42. doi:10.1111/j.1574-6968.1997.tb10263.x.
   PubMed Web of Science ®Google Scholar
• Hibberd ML, Mcconnell MM, Field AM, Rowe B. The fimbriae of human enterotoxigenic Escherichia coli strain 334 are related to CS5 fimbriae. J Gen Microbiol. 1990;136(12):2449–2456. doi:10.1099/00221287-136-12-2449.
   PubMedGoogle Scholar
• Hibberd ML, McConnell MM, Willshaw GA, Smith HR, Rowe B. Positive regulation of colonization factor antigen I (CFA/I) production by enterotoxigenic Escherichia coli producing the colonization factors CS5 CS6, CS7, CS17, PCFO9, PCFO159: H4 and PCFO166. J Gen Microbiol. 1991;137(8):1963–1970. doi:10.1099/00221287-137-8-1963.
   PubMedGoogle Scholar
• Taniguchi T, Akeda Y, Haba A, Yasuda Y, Yamamoto K, Honda T, Tochikubo K. Gene cluster for assembly of pilus colonization factor antigen III of enterotoxigenic Escherichia coli. Infect Immun. 2001;69(9):5864–5873. doi:10.1128/IAI.69.9.5864-5873.2001.
   PubMed Web of Science ®Google Scholar
• Darfeuille-Michaud A, Forestier C, Joly B, Cluzel R. Identification of a nonfimbrial adhesive factor of an enterotoxigenic Escherichia coli strain. Infect Immun. 1986;52(2):468–475. doi:10.1128/iai.52.2.468-475.1986.
   PubMed Web of Science ®Google Scholar
• Forestier C, Welinder KG, Darfeuille-Michaud A, Klemm P. Afimbrial adhesin from Escherichia coli strain 2230: purification, characterization and partial covalent structure. FEMS Microbiol Lett. 1987;40(1):47–50. doi:10.1111/j.1574-6968.1987.tb01980.x.
   Web of Science ®Google Scholar
• Knutton S, Lloyd DR, AS M. Identification of a new fimbrial structure in enterotoxigenic Escherichia coli (ETEC) serotype O148: H28 which adheres to human intestinal mucosa: a potentially new human ETEC colonization factor. Infect Immun. 1987;55(1):86–92. doi:10.1128/iai.55.1.86-92.1987.
   PubMed Web of Science ®Google Scholar
• Tacket C, Maneval D, Levine M. Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159: H4. Infect Immun. 1987;55(5):1063–1069. doi:10.1128/iai.55.5.1063-1069.1987.
   PubMed Web of Science ®Google Scholar
• Heuzenroeder MW, Elliot TR, Thomas CJ, Halter R, Manning PA. A new fimbrial type (PCFO9) on enterotoxigenic Escherichia coli 09: h− LT+ isolated from a case of infant diarrhea in central Australia. FEMS Microbiol Lett. 1990;66:55–60. doi:10.1016/0378-1097(90)90258-r.
   Web of Science ®Google Scholar
• Aubel D, Darfeuille-Michaud A, Joly B. New adhesive factor (antigen 8786) on a human enterotoxigenic Escherichia coli O117: H4 strain isolated in Africa. Infect Immun. 1991;59(4):1290–1299. doi:10.1128/iai.59.4.1290-1299.1991.
   PubMed Web of Science ®Google Scholar
• McConnell MM, Hibberd M, Field AM, Chart H, Rowe B. Characterization of a new putative colonization factor (CS17) from a human enterotoxigenic Escherichia coli of serotype 0114: 821 which produces only heat-labile enterotoxin. J Infect Dis. 1990;161(2):343–347. doi:10.1093/infdis/161.2.343.
   PubMed Web of Science ®Google Scholar
• Viboud GI, Binsztein N, Svennerholm A. A new fimbrial putative colonization factor, PCFO20, in human enterotoxigenic Escherichia coli. Infect Immun. 1993;61(12):5190–5197. doi:10.1128/iai.61.12.5190-5197.1993.
   PubMed Web of Science ®Google Scholar
• Viboud GI, Jonson G, Dean-Nystrom E, Svennerholm A-M. The structural gene encoding human Enterotoxigenic Escherichia coli PCFO20 is homologous to that for porcine 987P. Infect Immun. 1996;64(4):1233–1239. doi:10.1128/iai.64.4.1233-1239.1996.
   PubMed Web of Science ®Google Scholar
• Grewal H, Valvatne H, Bhan MK, van Dijk L, Gaastra W, Sommerfelt H. A new putative fimbrial colonization factor, CS19, of human Enterotoxigenic Escherichia coli. Infect Immun. 1997;65(2):507–513. doi:10.1128/iai.65.2.507-513.1997.
   PubMed Web of Science ®Google Scholar
• Valvatne H, Sommerfelt H, Gaastra W, Bhan MK, Grewal H. Identification and characterization of CS20, a new putative colonization factor of Enterotoxigenic Escherichia coli. Infect Immun. 1996;64(7):2635–2642. doi:10.1128/iai.64.7.2635-2642.1996.
   PubMed Web of Science ®Google Scholar
• Valvatne H, Steinsland H, Grewal HM, Mølbak K, Vuust J, Sommerfelt H. Identification and molecular characterization of the gene encoding coli surface antigen 20 of Enterotoxigenic Escherichia coli. FEMS Microbiol Lett. 2004;239(1):131–138. doi:10.1016/j.femsle.2004.08.028.
   PubMed Web of Science ®Google Scholar
• Girón JA, Levine MM, Kaper JB. Longus: a long pilus ultrastructure produced by human Enterotoxigenic Escherichia coli. Mol Microbiol. 1994;12(1):71–82. doi:10.1111/j.1365-2958.1994.tb00996.x.
   PubMed Web of Science ®Google Scholar
• Gomez-Duarte OG, Chattopadhyay S, Weissman SJ, Giron JA, Kaper JB, Sokurenko EV. Genetic diversity of the gene cluster encoding longus, a type IV pilus of enterotoxigenic Escherichia coli. J Bacteriol. 2007;189(24):9145–9149. doi:10.1128/JB.00722-07.
   PubMed Web of Science ®Google Scholar
• Pichel M, Binsztein N, Viboud G, O’Brien AD. CS22, a novel human Enterotoxigenic Escherichia coli adhesin, is related to CS15. Infect Immun. 2000;68(6):3280–3285. doi:10.1128/IAI.68.6.3280-3285.2000.
   PubMed Web of Science ®Google Scholar
• Del Canto F, Botkin DJ, Valenzuela P, Popov V, Ruiz-Perez F, Nataro JP, Levine MM, Stine OC, Pop M, Torres AG. Identification of coli surface antigen 23, a novel adhesin of Enterotoxigenic Escherichia coli. Infect Immun. 2012;80(8):2791–2801. doi:10.1128/IAI.00263-12.
   PubMed Web of Science ®Google Scholar
• Cádiz L, Torres A, Valdés R, Vera G, Gutiérrez D, Levine MM, Montero DA, O’Ryan M, Rasko DA, Stine OC. Coli surface antigen 26 acts as an adherence determinant of Enterotoxigenic Escherichia coli and is cross-recognized by anti-CS20 antibodies. Front Microbiol. 2018;9:2463. doi:10.3389/fmicb.2018.02463.
   PubMed Web of Science ®Google Scholar
• Nada RA, Shaheen HI, Khalil SB, Mansour A, El-Sayed N, Touni I, Weiner M, Armstrong AW, Klena JD. Discovery and phylogenetic analysis of novel members of class b Enterotoxigenic Escherichia coli adhesive fimbriae. J Clin Microbiol. 2011;49(4):1403–1410. doi:10.1128/JCM.02006-10.
   PubMed Web of Science ®Google Scholar
• von Mentzer A, Tobias J, Wiklund G, Nordqvist S, Aslett M, Dougan G, Å S, Svennerholm A-M. Identification and characterization of the novel colonization factor CS30 based on whole genome sequencing in Enterotoxigenic Escherichia coli (ETEC). Sci Rep. 2017;7(1):1–11. doi:10.1038/s41598-017-12743-3.
   PubMedGoogle Scholar
• Bourgeois AL, Wierzba TF, Walker RIJV. Status of vaccine research and development for Enterotoxigenic Escherichia coli. Vaccine. 2016;34(26):2880–2886. doi:10.1016/j.vaccine.2016.02.076.
   PubMed Web of Science ®Google Scholar
• Isidean S, Riddle M, Savarino S, Porter C. A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. Vaccine. 2011;29(37):6167–6178. doi:10.1016/j.vaccine.2011.06.084.
   PubMed Web of Science ®Google Scholar
• Gaastra W, Svennerholm A-M, Svennerholm A-M. Colonization factors of human Enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 1996;4(11):444–452. doi:10.1016/0966-842x(96)10068-8.
   PubMed Web of Science ®Google Scholar
• Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev. 2013;26(4):822–880. doi:10.1128/CMR.00022-13.
   PubMed Web of Science ®Google Scholar
• Paranchych W, Frost LS. The physiology and biochemistry of pili. Adv Microb Physiol. 1988;29:53–114. doi:10.1016/s0065-2911(08)60346-x.
   PubMed Web of Science ®Google Scholar
• Hospenthal MK, Costa TRD, Waksman G. A comprehensive guide to pilus biogenesis in gram-negative bacteria. Nat Rev Microbiol. 2017;15(6):365–379. doi:10.1038/nrmicro.2017.40.
   PubMed Web of Science ®Google Scholar
• Waksman G, Hultgren SJ. Structural biology of the chaperone-usher pathway of pilus biogenesis. Nat Rev Microbiol. 2009;7(11):765–774. doi:10.1038/nrmicro2220.
   PubMed Web of Science ®Google Scholar
• Craig L, Pique ME, Tainer JA. Type IV pilus structure and bacterial pathogenicity. Nat Rev Microbiol. 2004;2(5):363–378. doi:10.1038/nrmicro885.
   PubMed Web of Science ®Google Scholar
• Von Mentzer A, Zalem D, Chrienova Z, Teneberg S. Colonization factor CS30 from Enterotoxigenic Escherichia coli binds to sulfatide in human and porcine small intestine. Virulence. 2020;11(1):381–390. doi:10.1080/21505594.2020.1749497.
   PubMed Web of Science ®Google Scholar
• Vidal RM, Muhsen K, Tennant SM, Svennerholm A-M, Sow SO, Sur D, Zaidi AK, Faruque AS, Saha D, Adegbola R; JPntd. Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS). PLoS Negl Trop Dis. 2019;13(1):e0007037. doi:10.1371/journal.pntd.0007037.
   PubMed Web of Science ®Google Scholar
• Rivera FP, Medina AM, Aldasoro E, Sangil A, Gascon J, Ochoa TJ, Vila J, Ruiz J. Genotypic characterization of enterotoxigenic Escherichia coli strains causing traveler’s diarrhea. J Clin Microbiol. 2013;51(2):633–635. doi:10.1128/JCM.02572-12.
   PubMed Web of Science ®Google Scholar
• Beddoe T, Paton AW, Le Nours J, Rossjohn J, Paton JC; JTibs. Structure, biological functions and applications of the AB5 toxins. Trends Biochem Sci. 2010;35(7):411–418. doi:10.1016/j.tibs.2010.02.003.
   PubMed Web of Science ®Google Scholar
• Sixma TK, Pronk SE, Kalk KH, Wartna ES, van Zanten BA, Witholt B, Hoi WG. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature. 1991;351(6325):371–377. doi:10.1038/351371a0.
   PubMed Web of Science ®Google Scholar
• Liu D, Guo H, Zheng W, Zhang N, Wang T, Wang P, Ma X. Discovery of the cell-penetrating function of A 2 domain derived from LTA subunit of Escherichia coli heat-labile enterotoxin. Appl Microbiol Biotechnol. 2016;100(11):5079–5088. doi:10.1007/s00253-016-7423-x.
   PubMed Web of Science ®Google Scholar
• Fukuta S, Magnani JL, Twiddy EM, Holmes RK, Ginsburg V. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb. Infect Immun. 1988;56(7):1748–1753. doi:10.1128/iai.56.7.1748-1753.1988.
   PubMed Web of Science ®Google Scholar
• Ma Y. Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants. Expert Rev Vaccines. 2016;15(11):1361–1371. doi:10.1080/14760584.2016.1182868.
   PubMed Web of Science ®Google Scholar
• Jobling MG, Frisan T. The chromosomal nature of LT-II enterotoxins solved: a lambdoid prophage encodes both LT-II and one of two novel pertussis-toxin-like toxin family members in type II Enterotoxigenic Escherichia coli. Pathog Dis. 2016;74(3):ftw001. doi:10.1093/femspd/ftw001.
   PubMed Web of Science ®Google Scholar
• Norton EB, Lawson LB, Mahdi Z, Freytag LC, Clements JD, Payne SM. The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens. Infect Immun. 2012;80(7):2426–2435. doi:10.1128/IAI.00181-12.
   PubMed Web of Science ®Google Scholar
• Mirhoseini A, Amani J, Nazarian S. Review on pathogenicity mechanism of Enterotoxigenic Escherichia coli and vaccines against it. Microb Pathog. 2018;117:162–169. doi:10.1016/j.micpath.2018.02.032.
   PubMed Web of Science ®Google Scholar
• Nawar HF, King-Lyons ND, Hu JC, Pasek RC, Connell TD. LT-IIc, a new member of the type II heat-labile enterotoxin family encoded by an Escherichia coli sst. Infect Immun. 2010;78(11):4705–4713. doi:10.1128/IAI.00730-10.
   PubMed Web of Science ®Google Scholar
• Masso-Welch P, Girald Berlingeri S, King-Lyons ND, Mandell L, Hu J, Greene CJ, Federowicz M, Cao P, Connell TD, Heakal Y. LT-IIc, A bacterial type II heat-labile enterotoxin, induces specific lethality in triple negative breast cancer cells by modulation of autophagy and induction of apoptosis and necroptosis. Int J Mol Sci. 2018;20. doi:10.3390/ijms20010085.
   PubMed Web of Science ®Google Scholar
• Heggelund JE, Heim JB, Bajc G, Hodnik V, Anderluh G, Krengel U. Specificity of Escherichia coli heat-labile enterotoxin investigated by single-site mutagenesis and crystallography. Int J Mol Sci. 2019;20. doi:10.3390/ijms20030703.
   PubMed Web of Science ®Google Scholar
• Horstman AL, Kuehn MJ. Bacterial surface association of heat-labile enterotoxin through lipopolysaccharide after secretion via the general secretory pathway. J Biol Chem. 2002;277(36):32538–32545. doi:10.1074/jbc.M203740200.
   PubMed Web of Science ®Google Scholar
• Green ER, Mecsas J, Kudva IT. Bacterial secretion systems: an overview. Microbiol Spectr. 2016;4(1). doi:10.1128/microbiolspec.VMBF-0012-2015.
   Web of Science ®Google Scholar
• Yan Z, Yin M, Xu D, Zhu Y, Li X. Structural insights into the secretin translocation channel in the type II secretion system. Nat Struct Mol Biol. 2017;24(2):177–183. doi:10.1038/nsmb.3350.
   PubMed Web of Science ®Google Scholar
• Tauschek M, Gorrell RJ, Strugnell RA, Robins-Browne RM. Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc Natl Acad Sci U S A. 2002;99:7066–7071. doi:10.1073/pnas.092152899.
   PubMed Web of Science ®Google Scholar
• Korotkov KV, Sandkvist M, Hol WG. The type II secretion system: biogenesis, molecular architecture and mechanism. Nat Rev Microbiol. 2012;10(5):336–351. doi:10.1038/nrmicro2762.
   PubMed Web of Science ®Google Scholar
• Mudrak B, Rodriguez DL, Kuehn MJ. Residues of heat-labile enterotoxin involved in bacterial cell surface binding. J Bacteriol. 2009;191(9):2917–2925. doi:10.1128/JB.01622-08.
   PubMed Web of Science ®Google Scholar
• Horstman AL, Kuehn MJ. Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J Biol Chem. 2000;275(17):12489–12496. doi:10.1074/jbc.275.17.12489.
   PubMed Web of Science ®Google Scholar
• Ellis TN, Kuehn MJ. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 2010;74(1):81–94. doi:10.1128/MMBR.00031-09.
   PubMed Web of Science ®Google Scholar
• Roy K, Kansal R, Bartels SR, Hamilton DJ, Shaaban S, Fleckenstein JM. Adhesin degradation accelerates delivery of heat-labile toxin by enterotoxigenic Escherichia coli. J Biol Chem. 2011;286(34):29771–29779. doi:10.1074/jbc.M111.251546.
   PubMed Web of Science ®Google Scholar
• Kumar P, Luo Q, Vickers TJ, Sheikh A, Lewis WG, Fleckenstein JM, Payne SM. EatA, an immunogenic protective antigen of enterotoxigenic Escherichia coli, degrades intestinal mucin. Infect Immun. 2014;82(2):500–508. doi:10.1128/IAI.01078-13.
   PubMed Web of Science ®Google Scholar
• Luo Q, Kumar P, Vickers TJ, Sheikh A, Lewis WG, Rasko DA, Sistrunk J, Fleckenstein JM, Payne SM. Enterotoxigenic Escherichia coli secretes a highly conserved mucin-degrading metalloprotease to effectively engage intestinal epithelial cells. Infect Immun. 2014;82(2):509–521. doi:10.1128/IAI.01106-13.
   PubMed Web of Science ®Google Scholar
• Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 2004;23(23):4538–4549. doi:10.1038/sj.emboj.7600471.
   PubMed Web of Science ®Google Scholar
• Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8(1):26–38. doi:10.1038/nrmicro2265.
   PubMed Web of Science ®Google Scholar
• Duan Q, Xia P, Nandre R, Zhang W, Zhu G. Review of newly identified functions associated with the heat-labile toxin of Enterotoxigenic Escherichia coli. Front Cell Infect Microbiol. 2019;9:292. doi:10.3389/fcimb.2019.00292.
   PubMed Web of Science ®Google Scholar
• Lu X, Li C, Li C, Li P, Fu E, Xie Y, Jin F. Heat-labile enterotoxin-induced PERK-CHOP pathway activation causes intestinal epithelial cell apoptosis. Front Cell Infect Microbiol. 2017;7:244. doi:10.3389/fcimb.2017.00244.
   PubMed Web of Science ®Google Scholar
• Patry RT, Stahl M, Perez-Munoz ME, Nothaft H, Wenzel CQ, Sacher JC, Coros C, Walter J, Vallance BA, Szymanski CM. Bacterial AB 5 toxins inhibit the growth of gut bacteria by targeting ganglioside-like glycoconjugates. Nat Commun. 2019;10(1):1–13. doi:10.1038/s41467-019-09362-z.
   PubMedGoogle Scholar
• Subramenium GA, Sabui S, Marchant JS, Said HM, Subramanian VS. Enterotoxigenic Escherichia coli heat labile enterotoxin inhibits intestinal ascorbic acid uptake via a cAMP-dependent NF-κB-mediated pathway. Am J Physiol Gastrointest Liver Physiol. 2019;316(1):G55–G63. doi:10.1152/ajpgi.00259.2018.
   PubMed Web of Science ®Google Scholar
• Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209–222. doi:10.1016/s0140-6736(13)60844-2.
   PubMed Web of Science ®Google Scholar
• Joffre E, von Mentzer A, Svennerholm AM, Sjoling A. Identification of new heat-stable (STa) enterotoxin allele variants produced by human Enterotoxigenic Escherichia coli (ETEC). Int J Med Microbiol. 2016;306(7):586–594. doi:10.1016/j.ijmm.2016.05.016.
   PubMed Web of Science ®Google Scholar
• Basu N, Arshad N, Ssjm V; biochemistry c. Receptor guanylyl cyclase C (GC-C): regulation and signal transduction. Mol Cell Biochem. 2010;334(1–2):67–80. doi:10.1007/s11010-009-0324-x.
   PubMed Web of Science ®Google Scholar
• Weiglmeier PR, Rosch P, Berkner H. Cure and curse: e. coli heat-stable enterotoxin and its receptor guanylyl cyclase C. Toxins (Basel). 2010;2(9):2213–2229. doi:10.3390/toxins2092213.
   PubMed Web of Science ®Google Scholar
• Foreman DT, Martinez Y, Coombs G, Torres A, Kupersztoch YM. ToIC and DsbA are needed for the secretion of STB, a heat-stable enterotoxin of Escherichia coli. Mol Microbiol. 1995;18(2):237–245. doi:10.1111/j.1365-2958.1995.mmi_18020237.x.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhong Z, Luo Y, Cox E, Devriendt B. Heat-Stable enterotoxins of Enterotoxigenic Escherichia coli and their impact on host immunity. Toxins (Basel). 2019;11. doi:10.3390/toxins11010024.
   Web of Science ®Google Scholar
• Yamanaka H, Nomura T, Fujii Y, Okamoto K. Extracellular secretion of Escherichia coli heat-stable enterotoxin I across the outer membrane. J Bacteriol. 1997;179(11):3383–3390. doi:10.1128/jb.179.11.3383-3390.1997.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao Z, Guzmán‐Verduzco LM, Tachias K, Kupersztoch YM. Secretion of the STA3 heat-stable Enterotoxin of Escherichia coli: extracellular delivery of Pro-STA is accomplished by either Pro or STA. Mol Microbiol. 1992;6(23):3521–3529. doi:10.1111/j.1365-2958.1992.tb01787.x.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Luo Q, Davis SM, Westra C, Vickers TJ, Fleckenstein JM. Molecular determinants of Enterotoxigenic Escherichia coli heat-stable toxin secretion and delivery. Infect Immun. 2018;86(11):e00526–18. doi:10.1128/IAI.00526-18.
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Kameyama M, Baba T, Fujii Y, Okamoto K. Maturation pathway of Escherichia coli heat-stable enterotoxin I: requirement of DsbA for disulfide bond formation. J Bacteriol. 1994;176(10):2906–2913. doi:10.1128/jb.176.10.2906-2913.1994.
   PubMed Web of Science ®Google Scholar
• Vaandrager ABJM. biochemistry c. Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C. Mol Cell Biochem. 2002;230(1/2):73–83. doi:10.1023/A:1014231722696.
   PubMed Web of Science ®Google Scholar
• Vaandrager AB, Bot A, DeJonge HRJG. Guanosine 3’, 5’-cyclic monophosphate-dependent protein kinase II mediates heat-stable enterotoxin-provoked chloride secretion in rat intestine. Gastronterology. 1997;112(2):437–443. doi:10.1053/gast.1997.v112.pm9024297.
   PubMed Web of Science ®Google Scholar
• Forte L, Thorne P, Eber S, Krause W, Freeman R, Francis S, Corbin J. Stimulation of intestinal Cl-transport by heat-stable enterotoxin: activation of cAMP-dependent protein kinase by cGMP. Am J Physiol. 1992;263(3):C607–C15. doi:10.1152/ajpcell.1992.263.3.C607.
   PubMedGoogle Scholar
• Vaandrager AB, Bot AG, Ruth P, Pfeifer A, Hofmann F, De Jonge HRJG. Differential role of cyclic GMP–dependent protein kinase II in ion transport in murine small intestine and colon. Gastronterology. 2000;118(1):108–114. doi:10.1016/s0016-5085(00)70419-7.
   PubMed Web of Science ®Google Scholar
• Bagorda A, Guerra L, Di Sole F, Hemle-Kolb C, Cardone RA, Fanelli T, Reshkin SJ, Gisler SM, Murer H, Casavola V. Reciprocal protein kinase A regulatory interactions between cystic fibrosis transmembrane conductance regulator and Na+/H+ exchanger isoform 3 in a renal polarized epithelial cell model. J Biol Chem. 2002;277(24):21480–21488. doi:10.1074/jbc.M112245200.
   PubMed Web of Science ®Google Scholar
• Chen T, Lin R, Avula L, Sarker R, Yang J, Cha B, Tse CM, McNamara G, Seidler U, Waldman S, et al. NHERF3 is necessary for Escherichia coli heat-stable enterotoxin-induced inhibition of NHE3: differences in signaling in mouse small intestine and Caco-2 cells. Am J Physiol Cell Physiol. 2019;317(4):C737–C48. doi:10.1152/ajpcell.00351.2018.
   PubMed Web of Science ®Google Scholar
• Foulke-Abel J, Yu H, Sunuwar L, Lin R, Fleckenstein JM, Kaper JB, Donowitz M. Phosphodiesterase 5 (PDE5) restricts intracellular cGMP accumulation during Enterotoxigenic Escherichia coli infection. Gut Microbes. 2020;12(1):1752125. doi:10.1080/19490976.2020.1752125.
   PubMed Web of Science ®Google Scholar
• Kiefer MC, Motyka NI, Clements JD, Bitoun JP. Enterotoxigenic Escherichia coli heat-stable toxin increases the rate of zinc release from metallothionein and is a zinc- and iron-binding peptide. mSphere. 2020;5(2):e00146–20. doi:10.1128/mSphere.00146-20.
   PubMed Web of Science ®Google Scholar
• Sunuwar L, Yin J, Kasendra M, Karalis K, Kaper J, Fleckenstein J, Donowitz M. Mechanical stimuli affect Escherichia coli heat-stable enterotoxin-cyclic GMP signaling in a human enteroid intestine-chip model. Infect Immun. 2020;88(3):e00866–19. doi:10.1128/IAI.00866-19.
   PubMed Web of Science ®Google Scholar
• Li P, Lin JE, Snook AE, Waldman SA. ST-producing E. coli oppose carcinogen-induced colorectal tumorigenesis in mice. Toxins (Basel). 2017;9(9):279. doi:10.3390/toxins9090279.
   PubMed Web of Science ®Google Scholar
• Bijvelds MJ, Loos M, Bronsveld I, Hellemans A, Bongartz JP, Ver Donck L, Cox E, de Jonge HR, Schuurkes JA, De Maeyer JH. Inhibition of heat-stable toxin-induced intestinal salt and water secretion by a novel class of guanylyl cyclase C inhibitors. J Infect Dis. 2015;212(11):1806–1815. doi:10.1093/infdis/jiv300.
   PubMed Web of Science ®Google Scholar
• Fleckenstein JM, Lindler LE, Elsinghorst EA, Dale JB. Identification of a gene within a pathogenicity Island of Enterotoxigenic Escherichia coli H10407 required for maximal secretion of the heat-labile enterotoxin. Infect Immun. 2000;68(5):2766–2774. doi:10.1128/IAI.68.5.2766-2774.2000.
   PubMed Web of Science ®Google Scholar
• Elsinghorst EA, Kopecko D. Molecular cloning of epithelial cell invasion determinants from Enterotoxigenic Escherichia coli. Infect Immun. 1992;60(6):2409–2417. doi:10.1128/iai.60.6.2409-2417.1992.
   PubMed Web of Science ®Google Scholar
• Mammarappallil JG, Elsinghorst EA, O’Brien AD. Epithelial cell adherence mediated by the Enterotoxigenic Escherichia coli Tia protein. Infect Immun. 2000;68(12):6595–6601. doi:10.1128/IAI.68.12.6595-6601.2000.
   PubMed Web of Science ®Google Scholar
• Lindenthal C, Elsinghorst EA, Orndorff PE. Identification of a glycoprotein produced by enterotoxigenic Escherichia coli. Infect Immun. 1999;67(8):4084–4091. doi:10.1128/IAI.67.8.4084-4091.1999.
   PubMed Web of Science ®Google Scholar
• Lindenthal C, Elsinghorst EA. Enterotoxigenic Escherichia coli TibA glycoprotein adheres to human intestine epithelial cells. Infect Immun. 2001;69(1):52–57. doi:10.1128/IAI.69.1.52-57.2001.
   PubMed Web of Science ®Google Scholar
• Moormann C, Benz I, Schmidt MA. Functional substitution of the TibC protein of enterotoxigenic Escherichia coli strains for the autotransporter adhesin heptosyltransferase of the AIDA system. Infect Immun. 2002;70(5):2264–2270. doi:10.1128/IAI.70.5.2264-2270.2002.
   PubMed Web of Science ®Google Scholar
• Sherlock O, Vejborg RM, Klemm P. The TibA adhesin/invasin from enterotoxigenic Escherichia coli is self recognizing and induces bacterial aggregation and biofilm formation. Infect Immun. 2005;73(4):1954–1963. doi:10.1128/IAI.73.4.1954-1963.2005.
   PubMed Web of Science ®Google Scholar
• Kumar P, Kuhlmann FM, Bhullar K, Yang H, Vallance BA, Xia L, Luo Q, Fleckenstein JM. Dynamic interactions of a conserved Enterotoxigenic Escherichia coli adhesin with intestinal mucins govern epithelium engagement and toxin delivery. Infect Immun. 2016;84(12):3608–3617. doi:10.1128/IAI.00692-16.
   PubMed Web of Science ®Google Scholar
• Roy K, Hamilton D, Allen KP, Randolph MP, Fleckenstein JM. The EtpA exoprotein of Enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection. Infect Immun. 2008;76:2106–2112. doi:10.1128/IAI.01304-07.
   PubMed Web of Science ®Google Scholar
• Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, et al. Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity. J Clin Invest. 2018;128(8):3298–3311. doi:10.1172/JCI97659.
   PubMed Web of Science ®Google Scholar
• Sheikh A, Rashu R, Begum YA, Kuhlman FM, Ciorba MA, Hultgren SJ, Qadri F, Fleckenstein JM, Yang R. Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions. PLoS Negl Trop Dis. 2017;11(5):e0005586. doi:10.1371/journal.pntd.0005586.
   PubMed Web of Science ®Google Scholar
• Sheikh A, Luo Q, Roy K, Shabaan S, Kumar P, Qadri F, Fleckenstein JM, Payne SM. Contribution of the highly conserved EaeH surface protein to Enterotoxigenic Escherichia coli pathogenesis. Infect Immun. 2014;82(9):3657–3666. doi:10.1128/IAI.01890-14.
   PubMed Web of Science ®Google Scholar
• Patel SK, Dotson J, Allen KP, Fleckenstein JM. Identification and molecular characterization of eatA, an autotransporter protein of enterotoxigenic Escherichia coli. Infect Immun. 2004;72(3):1786–1794. doi:10.1128/IAI.72.3.1786-1794.2004.
   PubMed Web of Science ®Google Scholar
• Bin P, Tang Z, Liu S, Chen S, Xia Y, Liu J, Wu H, Zhu G. Intestinal microbiota mediates enterotoxigenic Escherichia coli-induced diarrhea in piglets. BMC Vet Res. 2018;14(1):1–13. doi:10.1186/s12917-018-1704-9.
   PubMedGoogle Scholar
• Pop M, Paulson JN, Chakraborty S, Astrovskaya I, Lindsay BR, Li S, Bravo HC, Harro C, Parkhill J, Walker AW. Individual-specific changes in the human gut microbiota after challenge with Enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment. BMC Genomics. 2016;17(1):1–11. doi:10.1186/s12864-016-2777-0.
   PubMedGoogle Scholar
• Allen KP, Randolph MM, Fleckenstein JM. Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strains. Infect Immun. 2006;74(2):869–875. doi:10.1128/IAI.74.2.869-875.2006.
   PubMed Web of Science ®Google Scholar
• Crofts AA, Giovanetti SM, Rubin EJ, Poly FM, Gutierrez RL, Talaat KR, Porter CK, Riddle MS, DeNearing B, Brubaker J, et al. Enterotoxigenic E. coli virulence gene regulation in human infections. Proc Natl Acad Sci U S A. 2018;115(38):E8968–E76. doi:10.1073/pnas.1808982115.
   PubMed Web of Science ®Google Scholar
• Wu Y, Ma N, Song P, He T, Levesque C, Bai Y, Zhang A and Ma X. Grape Seed Proanthocyanidin Affects Lipid Metabolism via Changing Gut Microflora and Enhancing Propionate Production in Weaned Pigs. The Journal of Nutrition. 2019;149(9):1523–1532. 10.1093/jn/nxz102.
   PubMed Web of Science ®Google Scholar
• Sommer F, Bäckhed F. The gut microbiota—masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227–238. doi:10.1038/nrmicro2974.
   PubMed Web of Science ®Google Scholar
• Kamada N, Seo S-U, Chen GY, Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013;13(5):321–335. doi:10.1038/nri3430.
   PubMed Web of Science ®Google Scholar
• Lawley TD, Walker AW. Intestinal colonization resistance. Immunology. 2013;138(1):1–11. doi:10.1111/j.1365-2567.2012.03616.x.
   PubMed Web of Science ®Google Scholar
• Bäumler AJ, Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016;535(7610):85–93. doi:10.1038/nature18849.
   PubMed Web of Science ®Google Scholar
• McKenney PT, Pamer EG. From hype to hope: the gut microbiota in enteric infectious disease. Cell. 2015;163(6):1326–1332. doi:10.1016/j.cell.2015.11.032.
   PubMed Web of Science ®Google Scholar
• Milshteyn A, Schneider JS, Brady SF. Mining the metabiome: identifying novel natural products from microbial communities. Chem Biol. 2014;21:1211–1223. doi:10.1016/j.chembiol.2014.08.006.
   PubMedGoogle Scholar
• Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota–gut–brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461–478. doi:10.1038/s41575-019-0157-3.
   PubMed Web of Science ®Google Scholar
• Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003;62(1):67–72. doi:10.1079/PNS2002207.
   PubMed Web of Science ®Google Scholar
• Cummings J, Pomare E, Branch W, Naylor C, MacFarlane G. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221–1227. doi:10.1136/gut.28.10.1221.
   PubMed Web of Science ®Google Scholar
• Shin R, Suzuki M, Morishita Y. Influence of intestinal anaerobes and organic acids on the growth of Enterohaemorrhagic Escherichia coli O157: H7. J Med Microbiol. 2002;51(3):201–206. doi:10.1099/0022-1317-51-3-201.
   PubMed Web of Science ®Google Scholar
• Roe AJ, O’Byrne C, McLaggan D, Booth IR. Inhibition of Escherichia coli growth by acetic acid: a problem with methionine biosynthesis and homocysteine toxicity. Microbiology. 2002;148(7):2215–2222. doi:10.1099/00221287-148-7-2215.
   PubMedGoogle Scholar
• Han K, Hong J, Lim HC. Relieving effects of glycine and methionine from acetic acid inhibition in Escherichia coli fermentation. Biotechnol Bioeng. 1993;41(3):316–324. doi:10.1002/bit.260410305.
   PubMed Web of Science ®Google Scholar
• Takashi K, Fujita I, Kobari K. Effects of short chain fatty acids on the production of heat-labile enterotoxin from enterotoxigenic Escherichia coli. Jpn J Pharmacol. 1989;50(4):495–498. doi:10.1254/jjp.50.495.
   PubMedGoogle Scholar
• Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91–119. doi:10.1016/B978-0-12-800100-4.00003-9.
   PubMed Web of Science ®Google Scholar
• Devlin AS, Fischbach MA. A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat Chem Biol. 2015;11(9):685–690. doi:10.1038/nchembio.1864.
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Chowdhury R. Bile and unsaturated fatty acids inhibit the binding of cholera toxin and Escherichia coli heat-labile enterotoxin to GM1 receptor. Antimicrob Agents Chemother. 2008;52(1):220–224. doi:10.1128/AAC.01009-07.
   PubMed Web of Science ®Google Scholar
• Dobson A, Cotter PD, Ross RP, Hill C. Bacteriocin production: a probiotic trait? Appl Environ Microbiol. 2012;78(1):1–6. doi:10.1128/AEM.05576-11.
   PubMed Web of Science ®Google Scholar
• Cotter PD, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol. 2005;3(10):777–788. doi:10.1038/nrmicro1273.
   PubMed Web of Science ®Google Scholar
• Soltani S, Hammami R, Cotter PD, Rebuffat S, Said LB, Gaudreau H, Bédard F, Biron E, Drider D, Fliss I. Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations. FEMS Microbiol Rev. 2021;45(1):fuaa039. doi:10.1093/femsre/fuaa039.
   PubMed Web of Science ®Google Scholar
• Gillor O, Giladi I, Riley MA. Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract. BMC Microbiol. 2009;9(1):1–7. doi:10.1186/1471-2180-9-165.
   PubMedGoogle Scholar
• Kleerebezem M, Quadri LE, Kuipers OP, De Vos WM. Quorum sensing by peptide pheromones and two‐component signal‐transduction systems in gram‐positive bacteria. Mol Microbiol. 1997;24(5):895–904. doi:10.1046/j.1365-2958.1997.4251782.x.
   PubMed Web of Science ®Google Scholar
• Duquesne S, Destoumieux-Garzón D, Peduzzi J, Rebuffat S. Microcins, gene-encoded antibacterial peptides from enterobacteria. Nat Prod Rep. 2007;24(4):708–734. doi:10.1039/b516237h.
   PubMed Web of Science ®Google Scholar
• Sassone-Corsi M, Nuccio S-P, Liu H, Hernandez D, Vu CT, Takahashi AA, Edwards RA, Raffatellu M. Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature. 2016;540(7632):280–283. doi:10.1038/nature20557.
   PubMed Web of Science ®Google Scholar
• Pelaseyed T, Bergström JH, Gustafsson JK, Ermund A, Birchenough GM, Schütte A, van der Post S, Svensson F, Rodríguez‐Piñeiro AM, Nyström EE. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev. 2014;260(1):8–20. doi:10.1111/imr.12182.
   PubMed Web of Science ®Google Scholar
• Johansson ME, Jakobsson HE, Holmén-Larsson J, Schütte A, Ermund A, Rodríguez-Piñeiro AM, Arike L, Wising C, Svensson F, Bäckhed F. Normalization of host intestinal mucus layers requires long-term microbial colonization. Cell Host Microbe. 2015;18(5):582–592. doi:10.1016/j.chom.2015.10.007.
   PubMed Web of Science ®Google Scholar
• Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A. 2008;105(52):20858–20863. doi:10.1073/pnas.0808723105.
   PubMed Web of Science ®Google Scholar
• McGuckin MA, Lindén SK, Sutton P, Florin TH. Mucin dynamics and enteric pathogens. Nat Rev Microbiol. 2011;9(4):265–278. doi:10.1038/nrmicro2538.
   PubMed Web of Science ®Google Scholar
• Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469(7331):543–547. doi:10.1038/nature09646.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485–498. doi:10.1016/j.cell.2009.09.033.
   PubMed Web of Science ®Google Scholar
• Chytilová M, Mudroňová D, Nemcová R, Gancarčíková S, Buleca V, Koščová J, Tkáčiková Ľ. Anti-inflammatory and immunoregulatory effects of flax-seed oil and lactobacillus plantarum–Biocenol™ LP96 in gnotobiotic pigs challenged with Enterotoxigenic Escherichia coli. Res Vet Sci. 2013;95(1):103–109. doi:10.1016/j.rvsc.2013.02.002.
   PubMed Web of Science ®Google Scholar
• Seo H, Zhang W. Development of effective vaccines for Enterotoxigenic Escherichia coli. Lancet Infect Dis. 2020;20(2):150–152. doi:10.1016/S1473-3099(19)30631-0.
   PubMed Web of Science ®Google Scholar
• Riddle M, Chen W, Kirkwood C, MacLennan C. Update on vaccines for enteric pathogens. Clin Microbiol Infect. 2018 1016/j.cmi.2018.06.023;24(10):1039–1045. doi:10.1016/j.cmi.2018.06.023.
   PubMed Web of Science ®Google Scholar
• Seo H, Duan Q, Zhang W. Vaccines against gastroenteritis, current progress and challenges. Gut Microbes. 2020;11(6):1486–1517. doi:10.1080/19490976.2020.1770666.
   PubMed Web of Science ®Google Scholar
• Nandre RM, Ruan X, Duan Q, Sack DA, Zhang W. Antibodies derived from an Enterotoxigenic Escherichia coli (ETEC) adhesin tip MEFA (multiepitope fusion antigen) against adherence of nine ETEC adhesins: CFA/I, CS1, CS2, CS3, CS4, CS5, CS6, CS21 and EtpA. Vaccine. 2016;34(31):3620–3625. doi:10.1016/j.vaccine.2016.04.003.
   PubMed Web of Science ®Google Scholar
• Zegeye ED, Govasli ML, Sommerfelt H, Puntervoll P. Development of an Enterotoxigenic Escherichia coli vaccine based on the heat-stable toxin. Hum Vaccin Immunother. 2019;15(6):1379–1388. doi:10.1080/21645515.2018.1496768.
   PubMed Web of Science ®Google Scholar
• Huang J, Duan Q, Zhang W, Dudley EG. Significance of Enterotoxigenic Escherichia coli (ETEC) heat-labile toxin (LT) enzymatic subunit epitopes in LT enterotoxicity and immunogenicity. Appl Environ Microbiol. 2018;84(15):e00849–18. doi:10.1128/AEM.00849-18.
   PubMed Web of Science ®Google Scholar
• Kuhlmann FM, Martin J, Hazen TH, Vickers TJ, Pashos M, Okhuysen PC, Gomez-Duarte OG, Cebelinski E, Boxrud D, Del Canto F, et al. Conservation and global distribution of non-canonical antigens in enterotoxigenic Escherichia coli. PLoS Negl Trop Dis. 2019;13(11):e0007825. doi:10.1371/journal.pntd.0007825.
   PubMed Web of Science ®Google Scholar
• Khalil I, Walker R, Porter CK, Muhib F, Chilengi R, Cravioto A, Guerrant R, Svennerholm A-M, Qadri F, Baqar S. Enterotoxigenic Escherichia coli (ETEC) vaccines: priority activities to enable product development, licensure, and global access. Vaccine. 2021;39(31):4266–4277. doi:10.1016/j.vaccine.2021.04.018.
   PubMed Web of Science ®Google Scholar
• Qadri F, Akhtar M, Bhuiyan TR, Chowdhury MI, Ahmed T, Rafique TA, Khan A, Rahman SIA, Khanam F, Lundgren A, et al. Safety and immunogenicity of the oral, inactivated, Enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial. Lancet Infect Dis. 2020;20(2):208–219. doi:10.1016/s1473-3099(19)30571-7.
   PubMed Web of Science ®Google Scholar
• Jertborn M, Åhrén C, Holmgren J, Svennerholm A-M. Safety and immunogenicity of an oral inactivated Enterotoxigenic Escherichia coli vaccine. Vaccine. 1998;16(2–3):255–260. doi:10.1016/s0264-410x(97)00169-2.
   PubMed Web of Science ®Google Scholar
• Lebens M, Shahabi V, Bäckström M, Houze T, Lindblad N, Holmgren J. Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine. Infect Immun. 1996;64(6):2144–2150. doi:10.1128/iai.64.6.2144-2150.1996.
   PubMed Web of Science ®Google Scholar
• Lundgren A, Bourgeois L, Carlin N, Clements J, Gustafsson B, Hartford M, Holmgren J, Petzold M, Walker R, Svennerholm A-M. Safety and immunogenicity of an improved oral inactivated multivalent Enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study. Vaccine. 2014;32(52):7077–7084. doi:10.1016/j.vaccine.2014.10.069.
   PubMed Web of Science ®Google Scholar
• Akhtar M, Chowdhury MI, Bhuiyan TR, Kaim J, Ahmed T, Rafique TA, Khan A, Rahman SI, Khanam F, Begum YA. Evaluation of the safety and immunogenicity of the oral inactivated multivalent Enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses. Vaccine. 2019;37(37):5645–5656. doi:10.1016/j.vaccine.2018.11.040.
   PubMed Web of Science ®Google Scholar
• Leach S, Lundgren A, Carlin N, Löfstrand M, Svennerholm A-M. Cross-reactivity and avidity of antibody responses induced in humans by the oral inactivated multivalent Enterotoxigenic Escherichia coli (ETEC) vaccine ETVAX. Vaccine. 2017;35(32):3966–3973. doi:10.1016/j.vaccine.2017.06.006.
   PubMed Web of Science ®Google Scholar
• Kotloff KL, Platts-Mills JA, Nasrin D, Roose A, Blackwelder WC, Levine MM. Global burden of diarrheal diseases among children in developing countries: incidence, etiology, and insights from new molecular diagnostic techniques. Vaccine. 2017;35(49):6783–6789. doi:10.1016/j.vaccine.2017.07.036.
   PubMed Web of Science ®Google Scholar
• Wolf MK. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of Enterotoxigenic Escherichia coli. Clin Microbiol Rev. 1997;10(4):569–584. doi:10.1128/CMR.10.4.569.
   PubMed Web of Science ®Google Scholar
• Zhang W, Sack DA. Progress and hurdles in the development of vaccines against Enterotoxigenic Escherichia coli in humans. Expert Rev Vaccines. 2012;11(6):677–694. doi:10.1586/erv.12.37.
   PubMed Web of Science ®Google Scholar
• Talaat KR, Porter CK, Bourgeois AL, Lee TK, Duplessis CA, Maciel M Jr., Gutierrez RL, DeNearing B, Adjoodani B, Adkinson R, et al. Oral delivery of hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic Escherichia coli as a prophylactic against diarrhea. Gut Microbes. 2020;12(1):1732852. doi:10.1080/19490976.2020.1732852.
   PubMed Web of Science ®Google Scholar
• Stoppato M, Gaspar C, Regeimbal J, Nunez RG, Giuntini S, Schiller ZA, Gawron MA, Pondish JR, Martin JC 3rd, Schneider MI, et al. Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model. Vaccine. 2020;38(10):2333–2339. doi:10.1016/j.vaccine.2020.01.064.
   PubMed Web of Science ®Google Scholar
• Rathe M, Muller K, Sangild PT, Husby S. Clinical applications of bovine colostrum therapy: a systematic review. Nutr Rev. 2014;72(4):237–254. doi:10.1111/nure.12089.
   PubMed Web of Science ®Google Scholar
• Sears KT, Tennant SM, Reymann MK, Simon R, Konstantopoulos N, Blackwelder WC, Barry EM, Pasetti MF. Bioactive immune components of anti-diarrheagenic Enterotoxigenic Escherichia coli hyperimmune bovine colostrum products. Clin Vaccine Immunol. 2017;24(8):e00186–16. doi:10.1128/CVI.00186-16.
   PubMedGoogle Scholar
• Tacket CO, Losonsky G, Link H, Hoang Y, Guesry P, Hilpert H, Levine MM. Protection by milk immunoglobulin concentrate against oral challenge with Enterotoxigenic Escherichia coli. N Engl J Med. 1988;318(19):1240–1243. doi:10.1056/NEJM198805123181904.
   PubMed Web of Science ®Google Scholar
• Otto W, Najnigier B, Stelmasiak T, Robins-Browne RM. Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by Enterotoxigenic Escherichia coli in volunteers. Scand J Gastroenterol. 2011;46(7–8):862–868. doi:10.3109/00365521.2011.574726.
   PubMed Web of Science ®Google Scholar
• Savarino SJ, McKenzie R, Tribble DR, Porter CK, O’Dowd A, Sincock SA, Poole ST, DeNearing B, Woods CM, Kim H, et al. hyperimmune bovine colostral anti-CS17 antibodies protect against Enterotoxigenic Escherichia coli diarrhea in a randomized, doubled-blind, placebo-controlled human infection model. J Infect Dis. 2019;220(3):505–513. doi:10.1093/infdis/jiz135.
   PubMed Web of Science ®Google Scholar
• Zheng W, Zhao W, Wu M, Song X, Caro F, Sun X, Gazzaniga F, Stefanetti G, Oh S, Mekalanos JJ, et al. Microbiota-targeted maternal antibodies protect neonates from enteric infection. Nature. 2020;577(7791):543–548. doi:10.1038/s41586-019-1898-4.
   PubMed Web of Science ®Google Scholar
• Hu Y, Kumru OS, Xiong J, Antunez LR, Hickey J, Wang Y, Cavacini L, Klempner M, Joshi SB, Volkin DB. Preformulation characterization and stability assessments of secretory IgA monoclonal antibodies as potential candidates for passive immunization by oral administration. J Pharm Sci. 2020;109(1):407–421. doi:10.1016/j.xphs.2019.07.018.
   PubMed Web of Science ®Google Scholar
• Tan P, Tang Q, Xu S, Zhang Y, Fu H and Ma X. Designing Self‐Assembling Chimeric Peptide Nanoparticles with High Stability for Combating Piglet Bacterial Infections. Advanced Science. 2022:2105955. 10.1002/advs.202105955.
   Web of Science ®Google Scholar
• Tan P, Fu H, Ma X. Design, optimization, and nanotechnology of antimicrobial peptides: from exploration to applications. Nano Today. 2021;39:101229. doi:10.1016/j.nantod.2021.101229.
   Web of Science ®Google Scholar
• Brown JW, Badahdah A, Iticovici M, Vickers TJ, Alvarado DM, Helmerhorst EJ, Oppenheim FG, Mills JC, Ciorba MA, Fleckenstein JM, et al. A role for salivary peptides in the innate defense against Enterotoxigenic Escherichia coli. J Infect Dis. 2018;217(9):1435–1441. doi:10.1093/infdis/jiy032.
   PubMed Web of Science ®Google Scholar
• Ding X, Yu H, Qiao S. Lasso peptide microcin J25 effectively enhances gut barrier function and modulates inflammatory response in an enterotoxigenic Escherichia coli-challenged mouse model. Int J Mol Sci. 2020;21(18):6500. doi:10.3390/ijms21186500.
   PubMed Web of Science ®Google Scholar
• Yu H, Ding X, Shang L, Zeng X, Liu H, Li N, Huang S, Wang Y, Wang G, Cai S, et al. Protective ability of biogenic antimicrobial peptide microcin J25 against Enterotoxigenic Escherichia Coli-induced intestinal epithelial dysfunction and inflammatory responses IPEC-J2 cells. Front Cell Infect Microbiol. 2018;8:242. doi:10.3389/fcimb.2018.00242.
   PubMed Web of Science ®Google Scholar
• Huang G, Li X, Lu D, Liu S, Suo X, Li Q, Li N. Lysozyme improves gut performance and protects against Enterotoxigenic Escherichia coli infection in neonatal piglets. Vet Res. 2018;49(1):20. doi:10.1186/s13567-018-0511-4.
   PubMedGoogle Scholar
• Guan G, Ding S, Yin Y, Duraipandiyan V, Al-Dhabi NA, Liu G. Macleaya cordata extract alleviated oxidative stress and altered innate immune response in mice challenged with Enterotoxigenic Escherichia coli. Sci China Life Sci. 2019;62(8):1019–1027. doi:10.1007/s11427-018-9494-6.
   PubMed Web of Science ®Google Scholar
• Xiong W, Huang J, Li X, Zhang Z, Jin M, Wang J, Xu Y, Wang Z. Icariin and its phosphorylated derivatives alleviate intestinal epithelial barrier disruption caused by Enterotoxigenic Escherichia coli through modulate p38 MAPK in vivo and in vitro. FASEB J. 2020;34(1):1783–1801. doi:10.1096/fj.201902265R.
   PubMed Web of Science ®Google Scholar
• Verhelst R, Schroyen M, Buys N, Niewold TAE. coli heat labile toxin (LT) inactivation by specific polyphenols is aggregation dependent. Vet Microbiol. 2013;163(3–4):319–324. doi:10.1016/j.vetmic.2012.12.039.
   PubMed Web of Science ®Google Scholar